Evidence for a novel gonadotropin-releasing hormone
in hypothalamic and forebrain areas in songbirds.
Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone
agonist during ovulation induction for in vitro fertilization.
A new compound heterozygous mutation of the gonadotropin-releasing hormone
receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.
Localization of gonadotropin-releasing hormone
in the central nervous system and a peripheral chemosensory organ of Aplysia californica.
2) Animal studies show a link between the hypothalamic-pituitary-adrenal axis and the hypothalamic-pituitary-ovarian axis in that acute corticotropin-releasing hormone administration to ovariectomized monkeys inhibits gonadotropin-releasing hormone
and luteinizing hormone.
Every morning, patients self-administered a 100-[micro]L dose of the spray containing 1 mg of deslorelin acetate, a gonadotropin-releasing hormone
Although there have been a number of studies on uterine leiomyomas in patients treated with gonadotropin-releasing hormone
agonists (GnRHAs), few have specifically addressed the vascular effects.
Leuprolide belongs to a class of medications called gonadotropin-releasing hormone
All patients underwent a long follicular gonadotropin-releasing hormone
agonist (GnRHa) protocol.
An alternative is to use the gonadotropin-releasing hormone
(GnRH) agonist deslorelin to suppress the pituitary-gonadal axis.
The researchers determined that activation of NF-kB reduced the synthesis of gonadotropin-releasing hormone
(GnRH, which is involved with reproduction) by the gland.
Value of suppression with a gonadotropin-releasing hormone
agonist prior to gonadotropin stimulation for in vitro fertilization.
They also discuss the normal physiology of folliculogenesis and the effect of stimulation; the use of oral contraceptives, clomiphene citrate, gonadotropin-releasing hormone
antagonists, and aromatase inhibitors; endometrial receptivity; follicular aspiration and flushing; single embryo transfer; cryopreserving techniques; patients with poor ovarian response and those at risk for ovarian hyperstimulation syndrome; low cost IVF for developing countries; a case study of one fertility center; and other aspects.
degarelix) a gonadotropin-releasing hormone
therapy (GnRH) approved for the treatment of advanced prostate cancer in both the EU and US, continued to be effective and well tolerated beyond three years.
Auterus-sparing therapy that combines delivery of progesterone via an intrauterine device with injections of gonadotropin-releasing hormone
appears to have preserved fertility in a majority of women treated for early endometrial cancer in a small prospective study.